旅游疫苗市场规模、份额、成长分析（按成分、按接种途径、按疾病、按旅行类型、按年龄层、按地区）－2025-2032 年行业预测

2023 年全球旅游疫苗市场规模价值为 51.9 亿美元，预计将从 2024 年的 57.4 亿美元成长到 2032 年的 119.3 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.6%。

由于健康意识的增强、国际旅行的增加以及政府积极的疫苗接种倡议，全球旅行疫苗市场正在经历显着增长。由于消费者优先保护自己的健康感染疾病，对预防措施的需求很大，并推动了疫苗开发和交付的创新。疫情后的旅行趋势增加了接种疫苗的紧迫性，特别是针对黄热病和甲型肝炎等疾病的疫苗接种，许多国家现在要求入境时提供疫苗接种证明。由于医疗基础设施不发达，新兴经济体对疫苗的需求激增。然而，挑战依然存在，例如疫苗储存的低温运输物流和监管复杂性。儘管存在这些障碍，政府、非政府组织和私营部门之间的合作对于发展市场和克服准入障碍至关重要。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 细分机会分析

市场动态与展望

• 市场概览
• 供需趋势分析
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 管道分析
• 专利分析
• 定价分析
• FDA分析
• 案例研究分析
• 技术评估

旅行疫苗市场规模（按成分和复合年增长率） (2025-2032)

• 市场概览
• 单药疫苗
• 联合疫苗

旅行疫苗市场规模（按接种途径和复合年增长率） (2025-2032)

• 市场概览
• 注射疫苗
• 鼻内疫苗
• 口服疫苗

旅行疫苗市场规模（依疾病区分）及复合年增长率（2025-2032）

• 市场概览
• 甲型肝炎
• 黄热病
• 伤寒
• B型肝炎
• 麻疹和腮腺炎
• 狂犬病
• 流感
• 其他的

旅行疫苗市场规模（按旅行类型和复合年增长率） (2025-2032)

• 市场概览
• 国内的
• 国外

旅行疫苗市场规模（依年龄层及复合年增长率） (2025-2032)

• 市场概览
• 婴儿
• 成人
• 老年人

旅行疫苗市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Pfizer
• Sanofi
• GlaxoSmithKline
• Merck & Co., Inc.
• AstraZeneca
• Abbott Laboratories
• F. Hoffmann-La Roche AG
• Takeda Pharmaceutical
• VBI Vaccine Inc.
• Bavarian Nordic
• CSL
• Valneva SE
• Johnson & Johnson Services Inc.（Crucell）
• Dynavax Technologies
• Novartis AG
• Bharat Biotech
• Emergent BioSolutions
• Hualan Biological Engineering Inc.
• Serum Institute of India Pvt. Ltd.
• Zydus Group

结论和建议

Global Travel Vaccines market size was valued at USD 5.19 Billion in 2023 and is poised to grow from USD 5.74 Billion in 2024 to USD 11.93 Billion by 2032, growing at a CAGR of 9.6% during the forecast period (2025-2032).

The global travel vaccine market is experiencing remarkable growth driven by heightened health awareness, increased international travel, and proactive government vaccination initiatives. As consumers prioritize health protection against infectious diseases, there's a notable demand for preventative measures, propelling innovation in vaccine development and delivery. Post-pandemic travel trends have enhanced the urgency for vaccinations, particularly for diseases like yellow fever and hepatitis A, with many countries imposing vaccination proof for entry. Emerging economies are seeing a surge in vaccine demand due to less developed health infrastructures. Yet, challenges such as cold-chain logistics for vaccine storage and regulatory complexities persist. Despite these hurdles, collaboration among governments, NGOs, and the private sector is crucial for market advancement and overcoming access barriers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Travel Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Travel Vaccines Market Segments Analysis

The global Travel Vaccines Market is segmented by Composition, Administration Route, Diseases, Travel Type, Age Group and region. Based on Composition, the market is segmented into Mono Vaccines and Combination Vaccines. Based on Administration Route, the market is segmented into Injectable Vaccines, Intranasal Vaccines and Oral Vaccines. Based on Diseases, the market is segmented into Hepatitis A, Yellow Fever, Typhoid, Hepatitis B, Measles & Mumps, Rabies, Influenza and Others. Based on Travel Type, the market is segmented into Domestic and Outbound. Based on Age Group, the market is segmented into Infants & Children, Adults and Elderly. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Travel Vaccines Market

The global travel vaccines market is significantly driven by the resurgence of international tourism, which has seen a remarkable recovery post-pandemic. In 2023, the UNWTO reported that international tourist arrivals climbed to 1.29 billion, marking a notable rebound. Countries such as Saudi Arabia and Australia have implemented strict vaccination requirements for travelers coming from endemic areas, specifically for diseases like yellow fever. This regulatory push has heightened the necessity for travel vaccines, resulting in impressive revenue growth for pharmaceutical companies. For instance, Sanofi highlighted a 10.4% increase in travel vaccine revenues in their 2023 annual report, illustrating the growing demand fueled by health regulations.

Restraints in the Global Travel Vaccines Market

The Global Travel Vaccines market faces significant constraints primarily due to the high out-of-pocket costs associated with these vaccines, which can deter individuals from seeking them. As reported by the CDC in 2023, common vaccines such as yellow fever and typhoid can range from $150 to $350 per dose, and most insurance plans do not cover these expenses. Companies, including Emergent BioSolutions, highlighted in their 2023 Annual Report that the affordability of vaccines is a major hurdle for broader market acceptance, especially among cost-sensitive travelers in developing nations. This financial barrier limits access and reduces the overall uptake of essential travel immunizations.

Market Trends of the Global Travel Vaccines Market

The Global Travel Vaccines market is experiencing a notable upward trend, particularly driven by heightened demand for COVID-19 booster doses as international travel regulations become increasingly stringent. With countries such as the U.S. and those in the EU enforcing updated vaccination requirements for travelers, pharmaceutical giants like Pfizer and Moderna are scaling production to meet this surge. Analysts project that sales of COVID-19 booster shots are set to grow by 15-20% in 2024, propelled by guidelines from authorities like the CDC, which emphasize the importance of booster vaccinations for individuals traveling to high-risk regions. This trend highlights the evolving landscape of travel health and safety.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Supply & Demand Trend Analysis
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Pipeline Analysis
• Patent Analysis
• Pricing Analysis
• FDA Analysis
• Case Study Analysis
• Technology Assessment

Global Travel Vaccines Market Size by Composition & CAGR (2025-2032)

• Market Overview
• Mono Vaccines
• Combination Vaccines

Global Travel Vaccines Market Size by Administration Route & CAGR (2025-2032)

• Market Overview
• Injectable Vaccines
• Intranasal Vaccines
• Oral Vaccines

Global Travel Vaccines Market Size by Diseases & CAGR (2025-2032)

• Market Overview
• Hepatitis A
• Yellow Fever
• Typhoid
• Hepatitis B
• Measles & Mumps
• Rabies
• Influenza
• Others

Global Travel Vaccines Market Size by Travel Type & CAGR (2025-2032)

• Market Overview
• Domestic
• Outbound

Global Travel Vaccines Market Size by Age Group & CAGR (2025-2032)

• Market Overview
• Infants & Children
• Adults
• Elderly

Global Travel Vaccines Market Size & CAGR (2025-2032)

• North America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • US
  • Canada
• Europe (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Composition, Administration Route, Diseases, Travel Type, Age Group)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VBI Vaccine Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Valneva SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson Services Inc. (Crucell)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent BioSolutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hualan Biological Engineering Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Serum Institute of India Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zydus Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations